Coty Inc.: Form 10-Q for the period ended Mar 31, 2024
Filed with the SEC on May 7, 2024 and accepted by EDGAR at May 7, 2024, 20:22 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2024-03-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2024-01-01 to 2024-03-31 | $1.39bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Revenue | 9 months2023-07-01 to 2024-03-31 | $4.75bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months2024-01-01 to 2024-03-31 | $487.8m | us-gaap:CostOfGoodsAndServicesSold |
| Cost of revenue | 9 months2023-07-01 to 2024-03-31 | $1.69bn | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months2024-01-01 to 2024-03-31 | $897.8m | us-gaap:GrossProfit |
| Gross profit | 9 months2023-07-01 to 2024-03-31 | $3.06bn | us-gaap:GrossProfit |
| Selling, general and administrative | 3 months2024-01-01 to 2024-03-31 | $770.6m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 9 months2023-07-01 to 2024-03-31 | $2.37bn | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2024-01-01 to 2024-03-31 | $77.8m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months2023-07-01 to 2024-03-31 | $512.0m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2024-01-01 to 2024-03-31 | $58.8m | us-gaap:InterestExpense |
| Interest expense | 9 months2023-07-01 to 2024-03-31 | $187.3m | us-gaap:InterestExpense |
| Income tax | 3 months2024-01-01 to 2024-03-31 | −$5.4m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months2023-07-01 to 2024-03-31 | $106.9m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2024-01-01 to 2024-03-31 | $3.8m | us-gaap:NetIncomeLoss |
| Net income | 9 months2023-07-01 to 2024-03-31 | $186.3m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2024-01-01 to 2024-03-31 | $0.00 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months2023-07-01 to 2024-03-31 | $0.20 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2024-01-01 to 2024-03-31 | $0.00 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months2023-07-01 to 2024-03-31 | $0.20 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2024-01-01 to 2024-03-31 | 892,000,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months2023-07-01 to 2024-03-31 | 886,100,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months2023-07-01 to 2024-03-31 | $438.1m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 9 months2023-07-01 to 2024-03-31 | $185.4m | us-gaap:PaymentsToAcquireProductiveAssets |
| Cash and equivalents | At period end2024-03-31 | $260.2m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2024-03-31 | $1.99bn | us-gaap:AssetsCurrent |
| Total assets | At period end2024-03-31 | $12.32bn | us-gaap:Assets |
| Current liabilities | At period end2024-03-31 | $2.48bn | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2024-03-31 | $7.90bn | us-gaap:Liabilities |
| Long-term debt | At period end2024-03-31 | $3.90bn | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | At period end2024-03-31 | $4.4m | us-gaap:DebtCurrent |
| Short-term borrowings | At period end2024-03-31 | $1.5m | us-gaap:ShortTermBorrowings |
| Shareholders' equity | At period end2024-03-31 | $3.99bn | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001024305-24-000023. Last ingested by Listed: Oct 24, 2026, 15:02 ET. Listed shows no prices and gives no investment advice.